The Discounted Cash Flow (DCF) valuation of CureVac NV (CVAC) is (26.95) USD. With the latest stock price at 3.19 USD, the upside of CureVac NV based on DCF is -944.9%.
Based on the latest price of 3.19 USD and our DCF valuation, CureVac NV (CVAC) is a sell. selling CVAC stocks now will result in a potential gain of 944.9%.
Note: valuation result may not be accurate due to the company's negative cashflows.
| Range | Selected | |
| WACC / Discount Rate | 7.2% - 9.7% | 8.5% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (53.98) - (17.96) | (26.95) |
| Upside | -1792.2% - -663.0% | -944.9% |